NasdaqCM - Nasdaq Real Time Price USD
IN8bio, Inc. (INAB)
0.1223
-0.0014
(-1.13%)
As of 1:33:11 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-19,352
-24,149
-23,340
-24,121
-13,509
Investing Cash Flow
-116
-187
-600
-3,705
-309
Financing Cash Flow
18,354
14,184
27,044
8,988
32,955
End Cash Position
12,157
11,120
21,282
18,182
37,272
Capital Expenditure
-2,598
-187
-600
-3,705
-309
Issuance of Capital Stock
13,678
9,943
24,564
9,542
36,327
Issuance of Debt
--
--
--
--
0
Repayment of Debt
-831
-794
-798
-615
-709
Free Cash Flow
-19,468
-24,336
-23,940
-27,826
-13,818
12/31/2021 - 7/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PSTV Plus Therapeutics, Inc.
0.3618
-4.51%
REVB Revelation Biosciences, Inc.
0.9124
+1.32%
PLRZ Polyrizon Ltd.
0.8449
+4.31%
TOVX Theriva Biologics, Inc.
0.4670
-2.43%
ASBP Aspire Biopharma Holdings, Inc.
0.3879
+1.04%
OGEN Oragenics, Inc.
3.6400
-17.28%
CDT Conduit Pharmaceuticals Inc.
2.6500
-17.96%
IMNN Imunon, Inc.
1.7150
-10.21%
NCNA NuCana plc
0.0470
-21.40%
TRAW Traws Pharma, Inc.
1.8100
-3.24%